Literature DB >> 16961776

Effect of rapamycin on renal ischemia-reperfusion injury in mice.

Sing Leung Lui1, Kwok Wah Chan, Ryan Tsang, Susan Yung, Kar Neng Lai, Tak Mao Chan.   

Abstract

The aim of this study was to determine the effect of rapamycin on renal ischemia-reperfusion injury (IRI) in mice. Renal IRI was induced in male BALB/c mice by clamping both renal pedicles for 45 min. The mice were treated with either vehicle or rapamycin (2 mg/kg/day) by oral gavage, starting 1 day before the IRI and continued daily till killing. The mice were killed on days 1, 3 and 7 after the operation. The severity of the renal IRI was assessed by serum creatinine levels and renal histology. Proliferation of renal tubular cells was quantified by immunohistochemical staining for proliferating cell nuclear antigen (PCNA). One day after the IRI, the serum creatinine levels of rapamycin-treated mice were significantly higher than those of the vehicle-treated mice. Kidney sections from rapamycin-treated mice showed more marked tubular damage and significantly lower number of PCNA-positive cells. The number of PCNA-positive cells in the rapamycin-treated mice remained significantly lower on day 3 after the IRI. By day 7 after the IRI, the serum creatinine levels, renal histology and positive PCNA staining in the kidney sections became similar between the two treatment groups. We conclude that in this murine model of renal IRI, rapamycin treatment aggravates renal IRI during the first 3 days after the insult. This effect might be mediated, at least partly, through inhibition of renal tubular cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16961776     DOI: 10.1111/j.1432-2277.2006.00361.x

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  16 in total

1.  Rapamycin protection of livers from ischemia and reperfusion injury is dependent on both autophagy induction and mammalian target of rapamycin complex 2-Akt activation.

Authors:  Jianjun Zhu; Tianfei Lu; Shi Yue; Xiuda Shen; Feng Gao; Ronald W Busuttil; Jerzy W Kupiec-Weglinski; Qiang Xia; Yuan Zhai
Journal:  Transplantation       Date:  2015-01       Impact factor: 4.939

Review 2.  Roles of mTOR complexes in the kidney: implications for renal disease and transplantation.

Authors:  Daniel Fantus; Natasha M Rogers; Florian Grahammer; Tobias B Huber; Angus W Thomson
Journal:  Nat Rev Nephrol       Date:  2016-08-01       Impact factor: 28.314

3.  Preconditioning donor with a combination of tacrolimus and rapamacyn to decrease ischaemia-reperfusion injury in a rat syngenic kidney transplantation model.

Authors:  F Cicora; J Roberti; D Vasquez; D Guerrieri; N Lausada; P Cicora; G Palti; E Chuluyan; P Gonzalez; P Stringa; C Raimondi
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

Review 4.  Prospects for mTOR inhibitor use in patients with polycystic kidney disease and hamartomatous diseases.

Authors:  Vicente E Torres; Alessandra Boletta; Arlene Chapman; Vincent Gattone; York Pei; Qi Qian; Darren P Wallace; Thomas Weimbs; Rudolf P Wüthrich
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-24       Impact factor: 8.237

5.  Mycophenolate mofetil modifies kidney tubular injury and Foxp3+ regulatory T cell trafficking during recovery from experimental ischemia-reperfusion.

Authors:  Maria Teresa Gandolfo; Hye Ryoun Jang; Serena M Bagnasco; Gang-Jee Ko; Patricia Agreda; Mark J Soloski; Michael T Crow; Hamid Rabb
Journal:  Transpl Immunol       Date:  2010-04-20       Impact factor: 1.708

Review 6.  mTOR inhibitors and renal allograft: Yin and Yang.

Authors:  Gianluigi Zaza; Simona Granata; Paola Tomei; Valentina Masola; Giovanni Gambaro; Antonio Lupo
Journal:  J Nephrol       Date:  2014-05-08       Impact factor: 3.902

7.  Sirolimus attenuates reduced-size liver ischemia-reperfusion injury but impairs liver regeneration in rats.

Authors:  Yuan-Xing Liu; Li-Ming Jin; Lin Zhou; Hai-Yang Xie; Guo-Ping Jiang; Hui Chen; Shu-Sen Zheng
Journal:  Dig Dis Sci       Date:  2009-10-24       Impact factor: 3.199

8.  Aged kidney: can we protect it? Autophagy, mitochondria and mechanisms of ischemic preconditioning.

Authors:  Stanislovas S Jankauskas; Denis N Silachev; Nadezda V Andrianova; Irina B Pevzner; Ljubava D Zorova; Vasily A Popkov; Egor Y Plotnikov; Dmitry B Zorov
Journal:  Cell Cycle       Date:  2018-07-25       Impact factor: 4.534

9.  Rapamycin Alternatively Modifies Mitochondrial Dynamics in Dendritic Cells to Reduce Kidney Ischemic Reperfusion Injury.

Authors:  Maria Namwanje; Bijay Bisunke; Thomas V Rousselle; Gene G Lamanilao; Venkatadri S Sunder; Elizabeth C Patterson; Canan Kuscu; Cem Kuscu; Daniel Maluf; Manjari Kiran; Valeria Mas; James D Eason; Amandeep Bajwa
Journal:  Int J Mol Sci       Date:  2021-05-20       Impact factor: 5.923

10.  Krüppel-like factor 6-mediated loss of BCAA catabolism contributes to kidney injury in mice and humans.

Authors:  Sian E Piret; Yiqing Guo; Ahmed A Attallah; Sylvia J Horne; Amy Zollman; Daniel Owusu; Justina Henein; Viktoriya S Sidorenko; Monica P Revelo; Takashi Hato; Avi Ma'ayan; John Cijiang He; Sandeep K Mallipattu
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.